If your fingers often feel swollen, stiff, or aching, it’s easy to blame it on aging. But finger swelling and pain can ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

Joni Kazantzis didn't think her psoriasis would turn into psoriatic arthritis. But the new diagnosis taught her—and her ...

Patients with psoriatic arthritis have delays in diagnosis compared with those with rheumatoid arthritis, according to study findings.

A shared neuroimmune pathway involving CRH, mast cells, and Th17 cells may underlie the link between psoriatic arthritis and ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Treatment today is focused on a “treat-to-target” strategy to treat rheumatoid arthritis, detailing specific treatments such as disease-modifying anti-rheumatic drugs (DMARDs) and the ...

The findings of the clinical trial confirm the treatment's safety and effectiveness. "The findings offer the first real solution in two decades for managing this rash, which frequently impacts ...